Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acacetin is a naturally occurring O-methylated flavone (flavonoid) found in several vascular plants, including *Robinia pseudoacacia* and *Agastache rugosa*. It exhibits diverse pharmacological activities, such as spasmolytic, anti-nociceptive, antioxidant, anti-inflammatory, anti-cancer, anti-plasmodial, antiarrhythmic, and neuroprotective effects. - **Mechanism of Action:** - Acacetin acts as an inhibitor of several enzymes and signaling pathways, including PI3K (phosphoinositide 3-kinase), RARγ (retinoic acid receptor-γ), BACE-1 (β-amyloid cleaving enzyme), and both monoamine oxidase isoforms (MAO-A and MAO-B), with a preference for MAO-B. - It modulates apoptotic pathways via caspase activation, influences cell cycle progression, inhibits ROS production, and affects MAPK, AKT, and Nrf2 signaling. - In the context of antibacterial activity, acacetin inhibits virulence factors such as listeriolysin O, suilysin, and pneumolysin, and also sortase A in bacteria. - Additional effects involve the suppression of inflammatory cytokines TNF-α, IL-6, and IL-1β via the Nrf2, AMPK, PI3K/AKT/IKK, and MAPK pathways. - In cardiovascular research, acacetin has demonstrated antiarrhythmic properties, particularly against atrial fibrillation. - **Indications:** Historically studied for chronic lymphocytic leukemia, hepatocellular carcinoma, oral squamous cell carcinoma, Alzheimer’s disease, neurodegenerative and inflammatory conditions, and arrhythmias[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acacetin.